메뉴 건너뛰기




Volumn 167, Issue 6, 2012, Pages 1200-1214

British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CLOBETASOL; CLOBETASOL PROPIONATE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; DAPSONE; DOXYCYCLINE; ETANERCEPT; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; OMALIZUMAB; PREDNISOLONE; PREDNISONE; RITUXIMAB; TACROLIMUS; TETRACYCLINE;

EID: 84870153040     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12072     Document Type: Review
Times cited : (120)

References (116)
  • 1
    • 62649125208 scopus 로고    scopus 로고
    • Writing a British Association of Dermatologists clinical guideline: An update on the process and guidance for authors
    • Bell HK, Ormerod AD,. Writing a British Association of Dermatologists clinical guideline: an update on the process and guidance for authors. Br J Dermatol 2009; 160: 725-8.
    • (2009) Br J Dermatol , vol.160 , pp. 725-728
    • Bell, H.K.1    Ormerod, A.D.2
  • 2
    • 77954608997 scopus 로고    scopus 로고
    • AGREE II: Advancing guideline development, reporting and evaluation in healthcare
    • Brouwers M, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J 2010; 182: E839-42.
    • (2010) Can Med Assoc J , vol.182
    • Brouwers, M.1    Kho, M.E.2    Browman, G.P.3
  • 3
    • 47849103273 scopus 로고    scopus 로고
    • Bullous pemphigoid and pemphigus vulgaris - Incidence and mortality in the UK: Population based cohort study
    • Langan SM, Smeeth L, Hubbard R, et al. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study. BMJ 2008; 337: a180.
    • (2008) BMJ , vol.337
    • Langan, S.M.1    Smeeth, L.2    Hubbard, R.3
  • 4
    • 65349194499 scopus 로고    scopus 로고
    • Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany
    • Bertram F, Brocker EB, Zillikens D, et al. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009; 7: 434-40.
    • (2009) J Dtsch Dermatol Ges , vol.7 , pp. 434-440
    • Bertram, F.1    Brocker, E.B.2    Zillikens, D.3
  • 5
    • 70349342924 scopus 로고    scopus 로고
    • Incidence of bullous pemphigoid and pemphigus in Switzerland: A 2-year prospective study
    • Marazza G, Pham HC, Scharer L, et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol 2009; 161: 861-8.
    • (2009) Br J Dermatol , vol.161 , pp. 861-868
    • Marazza, G.1    Pham, H.C.2    Scharer, L.3
  • 6
    • 84948725973 scopus 로고
    • Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group
    • Bernard P, Vaillant L, Labeille B, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 1995; 131: 48-52.
    • (1995) Arch Dermatol , vol.131 , pp. 48-52
    • Bernard, P.1    Vaillant, L.2    Labeille, B.3
  • 7
    • 78349285978 scopus 로고    scopus 로고
    • The association of bullous pemphigoid with cerebrovascular disease and dementia: A case-control study
    • Taghipour K, Chi CC, Vincent A, et al. The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. Arch Dermatol 2010; 146: 1251-4.
    • (2010) Arch Dermatol , vol.146 , pp. 1251-1254
    • Taghipour, K.1    Chi, C.C.2    Vincent, A.3
  • 8
    • 79951511421 scopus 로고    scopus 로고
    • Risk factors for bullous pemphigoid in the elderly: A prospective case-control study
    • Bastuji-Garin S, Joly P, Lemordant P, et al. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 2011; 131: 637-43.
    • (2011) J Invest Dermatol , vol.131 , pp. 637-643
    • Bastuji-Garin, S.1    Joly, P.2    Lemordant, P.3
  • 9
    • 79951512187 scopus 로고    scopus 로고
    • The relationship between neurological disease and bullous pemphigoid: A population-based case-control study
    • Langan SM, Groves RW, West J,. The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. J Invest Dermatol 2011; 131: 631-6.
    • (2011) J Invest Dermatol , vol.131 , pp. 631-636
    • Langan, S.M.1    Groves, R.W.2    West, J.3
  • 10
    • 80052270958 scopus 로고    scopus 로고
    • Comorbidity profiles among patients with bullous pemphigoid: A nationwide population-based study
    • Chen YJ, Wu CY, Lin MW, et al. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study. Br J Dermatol 2011; 165: 593-9.
    • (2011) Br J Dermatol , vol.165 , pp. 593-599
    • Chen, Y.J.1    Wu, C.Y.2    Lin, M.W.3
  • 11
    • 33746410713 scopus 로고    scopus 로고
    • Furosemide-induced bullous pemphigoid: Case report and review of literature
    • Lee JJ, Downham TF,. Furosemide-induced bullous pemphigoid: case report and review of literature. J Drugs Dermatol 2006; 5: 562-4.
    • (2006) J Drugs Dermatol , vol.5 , pp. 562-564
    • Lee, J.J.1    Downham, T.F.2
  • 12
    • 0028148149 scopus 로고
    • Enalapril and bullous eruptions
    • Mullins PD, Choudhury SL,. Enalapril and bullous eruptions. BMJ 1994; 309: 1411.
    • (1994) BMJ , vol.309 , pp. 1411
    • Mullins, P.D.1    Choudhury, S.L.2
  • 13
    • 33644675603 scopus 로고    scopus 로고
    • Bullous pemphigoid following therapy with an oral beta-blocker
    • Perry A, Sparling JD, Pennington M,. Bullous pemphigoid following therapy with an oral beta-blocker. J Drugs Dermatol 2005; 4: 746-8.
    • (2005) J Drugs Dermatol , vol.4 , pp. 746-748
    • Perry, A.1    Sparling, J.D.2    Pennington, M.3
  • 14
    • 0025190942 scopus 로고
    • Bullous pemphigoid - An adverse effect of ampicillin
    • Hodak E, Ben-Shetrit A, Ingber A, et al. Bullous pemphigoid-an adverse effect of ampicillin. Clin Exp Dermatol 1990; 15: 50-2.
    • (1990) Clin Exp Dermatol , vol.15 , pp. 50-52
    • Hodak, E.1    Ben-Shetrit, A.2    Ingber, A.3
  • 15
    • 72449143077 scopus 로고    scopus 로고
    • Bullous pemphigoid during long-term TNF-alpha blocker therapy
    • Bordignon M, Belloni-Fortina A, Pigozzi B, et al. Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology 2009; 219: 357-8.
    • (2009) Dermatology , vol.219 , pp. 357-358
    • Bordignon, M.1    Belloni-Fortina, A.2    Pigozzi, B.3
  • 16
    • 84856343351 scopus 로고    scopus 로고
    • Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin
    • Skandalis K, Spirova M, Gaitanis G, et al. Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin. J Eur Acad Dermatol Venereol 2012; 26: 249-53.
    • (2012) J Eur Acad Dermatol Venereol , vol.26 , pp. 249-253
    • Skandalis, K.1    Spirova, M.2    Gaitanis, G.3
  • 17
    • 0029865652 scopus 로고    scopus 로고
    • Drugs associated with bullous pemphigoid: A case-control study
    • Bastuji GS, Joly P, Picard DC, et al. Drugs associated with bullous pemphigoid: a case-control study. Arch Dermatol 1996; 132: 272-6.
    • (1996) Arch Dermatol , vol.132 , pp. 272-276
    • Bastuji, G.S.1    Joly, P.2    Picard, D.C.3
  • 18
    • 84871284616 scopus 로고    scopus 로고
    • The associations between bullous pemphigoid and drug use: A UK case-control study
    • (in press)
    • Lloyd-Lavery A, Chi CC, Wojnarowska F, et al. The associations between bullous pemphigoid and drug use: a UK case-control study. Arch Dermatol 2012; (in press).
    • (2012) Arch Dermatol
    • Lloyd-Lavery, A.1    Chi, C.C.2    Wojnarowska, F.3
  • 19
    • 10444236353 scopus 로고    scopus 로고
    • Enhanced diagnostic immunofluorescence using biopsies transported in saline
    • Vodegel RM, de Jong MC, Meijer HJ, et al. Enhanced diagnostic immunofluorescence using biopsies transported in saline. BMC Dermatol 2004; 4: 10.
    • (2004) BMC Dermatol , vol.4 , pp. 10
    • Vodegel, R.M.1    De Jong, M.C.2    Meijer, H.J.3
  • 20
    • 0029051840 scopus 로고
    • The use of Michel's transport medium for immunofluorescence and immunoelectron microscopy in autoimmune bullous diseases
    • Vaughan Jones SA, Palmer I, Bhogal BS, et al. The use of Michel's transport medium for immunofluorescence and immunoelectron microscopy in autoimmune bullous diseases. J Cutan Pathol 1995; 22: 365-70.
    • (1995) J Cutan Pathol , vol.22 , pp. 365-370
    • Vaughan Jones, S.A.1    Palmer, I.2    Bhogal, B.S.3
  • 21
    • 79952826620 scopus 로고    scopus 로고
    • Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid
    • Roussel A, Benichou J, Randriamanantany ZA, et al. Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid. Arch Dermatol 2011; 147: 293-8.
    • (2011) Arch Dermatol , vol.147 , pp. 293-298
    • Roussel, A.1    Benichou, J.2    Randriamanantany, Z.A.3
  • 22
    • 79952859900 scopus 로고    scopus 로고
    • Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: A retrospective study of 138 patients
    • Charneux J, Lorin J, Vitry F, et al. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. Arch Dermatol 2011; 147: 286-91.
    • (2011) Arch Dermatol , vol.147 , pp. 286-291
    • Charneux, J.1    Lorin, J.2    Vitry, F.3
  • 23
    • 74549201112 scopus 로고    scopus 로고
    • Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects
    • Wieland CN, Comfere NI, Gibson LE, et al. Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects. Arch Dermatol 2010; 146: 21-5.
    • (2010) Arch Dermatol , vol.146 , pp. 21-25
    • Wieland, C.N.1    Comfere, N.I.2    Gibson, L.E.3
  • 24
    • 0036288111 scopus 로고    scopus 로고
    • Risk factors for lethal outcome in patients with bullous pemphigoid: Low serum albumin level, high dosage of glucocorticosteroids, and old age
    • Rzany B, Partscht K, Jung M, et al. Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Arch Dermatol 2002; 138: 903-8.
    • (2002) Arch Dermatol , vol.138 , pp. 903-908
    • Rzany, B.1    Partscht, K.2    Jung, M.3
  • 25
    • 0002659723 scopus 로고
    • Treatment in bullous diseases with corticosteroid drugs and corticotrophin
    • Stevenson CJ,. Treatment in bullous diseases with corticosteroid drugs and corticotrophin. Br J Dermatol 1960; 72: 11-21.
    • (1960) Br J Dermatol , vol.72 , pp. 11-21
    • Stevenson, C.J.1
  • 26
    • 0010423711 scopus 로고
    • Pemphigoid treated with corticosteroids
    • Church R,. Pemphigoid treated with corticosteroids. Br J Dermatol 1960; 72: 434-8.
    • (1960) Br J Dermatol , vol.72 , pp. 434-438
    • Church, R.1
  • 27
    • 0021179852 scopus 로고
    • Plasma exchange in bullous pemphigoid
    • Roujeau JC, Guillaume JC, Morel P, et al. Plasma exchange in bullous pemphigoid. Lancet 1984; 2: 486-8.
    • (1984) Lancet , vol.2 , pp. 486-488
    • Roujeau, J.C.1    Guillaume, J.C.2    Morel, P.3
  • 28
    • 0021668530 scopus 로고
    • Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study
    • (in French)
    • Morel P, Guillaume JC,. [Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study]. Ann Dermatol Venereol 1984; 111: 925-8. (in French).
    • (1984) Ann Dermatol Venereol , vol.111 , pp. 925-928
    • Morel, P.1    Guillaume, J.C.2
  • 29
    • 0027475229 scopus 로고
    • Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid
    • Guillaume JC, Vaillant L, Bernard P, et al. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol 1993; 129: 49-53.
    • (1993) Arch Dermatol , vol.129 , pp. 49-53
    • Guillaume, J.C.1    Vaillant, L.2    Bernard, P.3
  • 30
    • 0037204199 scopus 로고    scopus 로고
    • A comparison of oral and topical corticosteroids in patients with bullous pemphigoid
    • Joly P, Roujeau JC, Benichou J, et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002; 346: 321-7.
    • (2002) N Engl J Med , vol.346 , pp. 321-327
    • Joly, P.1    Roujeau, J.C.2    Benichou, J.3
  • 31
    • 0021212157 scopus 로고
    • High-dose methylprednisolone in the treatment of bullous pemphigoid
    • Siegel J, Eaglstein WH,. High-dose methylprednisolone in the treatment of bullous pemphigoid. Arch Dermatol 1984; 120: 1157-65.
    • (1984) Arch Dermatol , vol.120 , pp. 1157-1165
    • Siegel, J.1    Eaglstein, W.H.2
  • 32
    • 84858717756 scopus 로고    scopus 로고
    • Practice gaps. Improving the care of our patients who are receiving glucocorticoid therapy
    • Albrecht J, Werth VP,. Practice gaps. Improving the care of our patients who are receiving glucocorticoid therapy. Arch Dermatol 2012; 148: 314-15.
    • (2012) Arch Dermatol , vol.148 , pp. 314-315
    • Albrecht, J.1    Werth, V.P.2
  • 33
    • 84865584216 scopus 로고    scopus 로고
    • Evidence for vitamin D deficiency and increased prevalence of fractures in autoimmune bullous skin diseases
    • Marzano AV, Trevisan V, Eller-Vainicher C, et al. Evidence for vitamin D deficiency and increased prevalence of fractures in autoimmune bullous skin diseases. Br J Dermatol 2012; 167: 688-91.
    • (2012) Br J Dermatol , vol.167 , pp. 688-691
    • Marzano, A.V.1    Trevisan, V.2    Eller-Vainicher, C.3
  • 34
    • 84858722483 scopus 로고    scopus 로고
    • Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: A randomized, double-blind, placebo-controlled study
    • Tee SI, Yosipovitch G, Chan YC, et al. Prevention of glucocorticoid- induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study. Arch Dermatol 2012; 148: 307-14.
    • (2012) Arch Dermatol , vol.148 , pp. 307-314
    • Tee, S.I.1    Yosipovitch, G.2    Chan, Y.C.3
  • 35
    • 0028260082 scopus 로고
    • Bioavailability and reversible metabolism of prednisone and prednisolone in man
    • Garg V, Jusko WJ,. Bioavailability and reversible metabolism of prednisone and prednisolone in man. Biopharm Drug Dispos 1994; 15: 163-72.
    • (1994) Biopharm Drug Dispos , vol.15 , pp. 163-172
    • Garg, V.1    Jusko, W.J.2
  • 36
    • 0027154612 scopus 로고
    • Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone
    • Rollin C, Chosidow O, Diquet B, et al. Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone. Eur J Clin Pharmacol 1993; 44: 395-9.
    • (1993) Eur J Clin Pharmacol , vol.44 , pp. 395-399
    • Rollin, C.1    Chosidow, O.2    Diquet, B.3
  • 37
    • 0032987394 scopus 로고    scopus 로고
    • Prospective study of treatment of bullous pemphigoid by a class i topical corticosteroid
    • Zimmermann R, Faure M, Claudy A,. Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid. Ann Dermatol Venereol 1999; 126: 13-16.
    • (1999) Ann Dermatol Venereol , vol.126 , pp. 13-16
    • Zimmermann, R.1    Faure, M.2    Claudy, A.3
  • 38
    • 67449132596 scopus 로고    scopus 로고
    • A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: A multicenter randomized study
    • Joly P, Roujeau JC, Benichou J, et al. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol 2009; 129: 1681-7.
    • (2009) J Invest Dermatol , vol.129 , pp. 1681-1687
    • Joly, P.1    Roujeau, J.C.2    Benichou, J.3
  • 40
    • 84871336474 scopus 로고    scopus 로고
    • The approach of UK dermatologists to the treatment of bullous pemphigoid - Results of a national survey
    • (in press)
    • Taghipour K, Mohd Mustapa MF, Highet AS, et al. The approach of UK dermatologists to the treatment of bullous pemphigoid-results of a national survey. Clin Exp Dermatol 2012; (in press).
    • (2012) Clin Exp Dermatol
    • Taghipour, K.1    Mohd Mustapa, M.F.2    Highet, A.S.3
  • 41
    • 0018175289 scopus 로고
    • Azathioprine plus prednisone in treatment of pemphigoid
    • Burton JL, Harman RR, Peachey RD, et al. Azathioprine plus prednisone in treatment of pemphigoid. BMJ 1978; 2: 1190-1.
    • (1978) BMJ , vol.2 , pp. 1190-1191
    • Burton, J.L.1    Harman, R.R.2    Peachey, R.D.3
  • 42
    • 37249036129 scopus 로고    scopus 로고
    • A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid
    • Beissert S, Werfel T, Frieling U, et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. Arch Dermatol 2007; 143: 1536-42.
    • (2007) Arch Dermatol , vol.143 , pp. 1536-1542
    • Beissert, S.1    Werfel, T.2    Frieling, U.3
  • 43
    • 47849114078 scopus 로고    scopus 로고
    • Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid
    • Bystryn JC,. Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid. Arch Dermatol 2008; 144: 946.
    • (2008) Arch Dermatol , vol.144 , pp. 946
    • Bystryn, J.C.1
  • 44
    • 80053484439 scopus 로고    scopus 로고
    • British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011
    • Meggitt SJ, Anstey AV, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011. Br J Dermatol 2011; 165: 711-34.
    • (2011) Br J Dermatol , vol.165 , pp. 711-734
    • Meggitt, S.J.1    Anstey, A.V.2    Mohd Mustapa, M.F.3
  • 45
    • 61449121097 scopus 로고    scopus 로고
    • Results of a survey of German dermatologists on the therapeutic approaches to pemphigus and bullous pemphigoid
    • Hofmann SC, Kautz O, Hertl M, et al. Results of a survey of German dermatologists on the therapeutic approaches to pemphigus and bullous pemphigoid. J Dtsch Dermatol Ges 2009; 7: 227-33.
    • (2009) J Dtsch Dermatol Ges , vol.7 , pp. 227-233
    • Hofmann, S.C.1    Kautz, O.2    Hertl, M.3
  • 46
    • 0028285571 scopus 로고
    • Nicotinamide and tetracycline therapy of bullous pemphigoid
    • Fivenson DP, Breneman DL, Rosen GB, et al. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol 1994; 130: 753-8.
    • (1994) Arch Dermatol , vol.130 , pp. 753-758
    • Fivenson, D.P.1    Breneman, D.L.2    Rosen, G.B.3
  • 47
    • 0027530439 scopus 로고
    • Treatment of generalized bullous pemphigoid with oral tetracycline
    • Thomas I, Khorenian S, Arbesfeld DM,. Treatment of generalized bullous pemphigoid with oral tetracycline. J Am Acad Dermatol 1993; 28: 74-7.
    • (1993) J Am Acad Dermatol , vol.28 , pp. 74-77
    • Thomas, I.1    Khorenian, S.2    Arbesfeld, D.M.3
  • 48
    • 0029760518 scopus 로고    scopus 로고
    • Eleven cases of bullous pemphigoid treated with a combination of minocycline and nicotinamide
    • Kawahara Y, Hashimoto T, Ohata Y, et al. Eleven cases of bullous pemphigoid treated with a combination of minocycline and nicotinamide. Eur J Dermatol 1996; 6: 427-9.
    • (1996) Eur J Dermatol , vol.6 , pp. 427-429
    • Kawahara, Y.1    Hashimoto, T.2    Ohata, Y.3
  • 49
    • 0029054026 scopus 로고
    • Bullous pemphigoid successfully controlled by tetracycline and nicotinamide
    • Kolbach DN, Remme JJ, Bos WH, et al. Bullous pemphigoid successfully controlled by tetracycline and nicotinamide. Br J Dermatol 1995; 133: 88-90.
    • (1995) Br J Dermatol , vol.133 , pp. 88-90
    • Kolbach, D.N.1    Remme, J.J.2    Bos, W.H.3
  • 50
    • 0031038326 scopus 로고    scopus 로고
    • Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol
    • Hornschuh B, Hamm H, Wever S, et al. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol. J Am Acad Dermatol 1997; 36: 101-3.
    • (1997) J Am Acad Dermatol , vol.36 , pp. 101-103
    • Hornschuh, B.1    Hamm, H.2    Wever, S.3
  • 51
    • 0031468624 scopus 로고    scopus 로고
    • Treatment of bullous pemphigoid with tetracyclines and topical corticosteroids
    • Depaire-Duclos F, Dandurand M, Basset-Seguin N, et al. Treatment of bullous pemphigoid with tetracyclines and topical corticosteroids. Eur J Dermatol 1997; 7: 570-3.
    • (1997) Eur J Dermatol , vol.7 , pp. 570-573
    • Depaire-Duclos, F.1    Dandurand, M.2    Basset-Seguin, N.3
  • 52
    • 79956084512 scopus 로고    scopus 로고
    • Nonbullous pemphigoid treated with doxycycline monotherapy: Report of 4 cases
    • Safa G, Darrieux L,. Nonbullous pemphigoid treated with doxycycline monotherapy: report of 4 cases. J Am Acad Dermatol 2011; 64: e116-18.
    • (2011) J Am Acad Dermatol , vol.64
    • Safa, G.1    Darrieux, L.2
  • 53
    • 0019993283 scopus 로고
    • Erythromycin therapy in bullous pemphigoid: Possible anti-inflammatory effects
    • Fox BJ, Odom RB, Findlay RF,. Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects. J Am Acad Dermatol 1982; 7: 504-10.
    • (1982) J Am Acad Dermatol , vol.7 , pp. 504-510
    • Fox, B.J.1    Odom, R.B.2    Findlay, R.F.3
  • 54
    • 0032741511 scopus 로고    scopus 로고
    • Treatment of bullous pemphigoid with erythromycin: A reappraisal
    • Altomare G, Capella GL, Fracchiolla C, et al. Treatment of bullous pemphigoid with erythromycin: a reappraisal. Eur J Dermatol 1999; 9: 583-5.
    • (1999) Eur J Dermatol , vol.9 , pp. 583-585
    • Altomare, G.1    Capella, G.L.2    Fracchiolla, C.3
  • 55
    • 0025708149 scopus 로고
    • Therapy of bullous pemphigoid with erythromycin
    • (in German)
    • Mensing H, Krausse S,. [Therapy of bullous pemphigoid with erythromycin]. Med Klin 1990; 85: 481-4 (in German).
    • (1990) Med Klin , vol.85 , pp. 481-484
    • Mensing, H.1    Krausse, S.2
  • 56
    • 0032134724 scopus 로고    scopus 로고
    • Autoimmune bullous eruption localized to a breast reconstruction site: Response to niacinamide
    • Honl BA, Elston DM,. Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide. Cutis 1998; 62: 85-6.
    • (1998) Cutis , vol.62 , pp. 85-86
    • Honl, B.A.1    Elston, D.M.2
  • 57
    • 0032947756 scopus 로고    scopus 로고
    • Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid
    • Heilborn JD, Stahle-Backdahl M, Albertioni F, et al. Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid. J Am Acad Dermatol 1999; 40: 741-9.
    • (1999) J Am Acad Dermatol , vol.40 , pp. 741-749
    • Heilborn, J.D.1    Stahle-Backdahl, M.2    Albertioni, F.3
  • 58
    • 0242576335 scopus 로고    scopus 로고
    • Methotrexate for bullous pemphigoid: Preliminary study
    • Bara C, Maillard H, Briand N, et al. Methotrexate for bullous pemphigoid: preliminary study. Arch Dermatol 2003; 139: 1506-7.
    • (2003) Arch Dermatol , vol.139 , pp. 1506-1507
    • Bara, C.1    Maillard, H.2    Briand, N.3
  • 59
    • 82255194113 scopus 로고    scopus 로고
    • Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: An open, multicentre, retrospective study
    • Du-Thanh A, Merlet S, Maillard H, et al. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study. Br J Dermatol 2011; 165: 1337-43.
    • (2011) Br J Dermatol , vol.165 , pp. 1337-1343
    • Du-Thanh, A.1    Merlet, S.2    Maillard, H.3
  • 60
    • 44249123048 scopus 로고    scopus 로고
    • A retrospective analysis of patients with bullous pemphigoid treated with methotrexate
    • Kjellman P, Eriksson H, Berg P,. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate. Arch Dermatol 2008; 144: 612-16.
    • (2008) Arch Dermatol , vol.144 , pp. 612-616
    • Kjellman, P.1    Eriksson, H.2    Berg, P.3
  • 61
  • 62
    • 0031583131 scopus 로고    scopus 로고
    • Bullous pemphigoid treated with mycophenolate mofetil
    • Bohm M, Beissert S, Schwarz T, et al. Bullous pemphigoid treated with mycophenolate mofetil. Lancet 1997; 349: 541.
    • (1997) Lancet , vol.349 , pp. 541
    • Bohm, M.1    Beissert, S.2    Schwarz, T.3
  • 63
    • 0033001608 scopus 로고    scopus 로고
    • Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy
    • Grundmann-Kollmann M, Kaskel P, Leiter U, et al. Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy. Arch Dermatol 1999; 135: 724-5.
    • (1999) Arch Dermatol , vol.135 , pp. 724-725
    • Grundmann-Kollmann, M.1    Kaskel, P.2    Leiter, U.3
  • 65
    • 0024535246 scopus 로고
    • Dapsone as first-line therapy for bullous pemphigoid
    • Venning VA, Millard PR, Wojnarowska F,. Dapsone as first-line therapy for bullous pemphigoid. Br J Dermatol 1989; 120: 83-92.
    • (1989) Br J Dermatol , vol.120 , pp. 83-92
    • Venning, V.A.1    Millard, P.R.2    Wojnarowska, F.3
  • 66
    • 0030005201 scopus 로고    scopus 로고
    • Treatment of bullous pemphigoid with dapsone: Retrospective study of thirty-six cases
    • Bouscarat F, Chosidow O, Picard-Dahan C, et al. Treatment of bullous pemphigoid with dapsone: retrospective study of thirty-six cases. J Am Acad Dermatol 1996; 34: 683-4.
    • (1996) J Am Acad Dermatol , vol.34 , pp. 683-684
    • Bouscarat, F.1    Chosidow, O.2    Picard-Dahan, C.3
  • 67
    • 0017735587 scopus 로고
    • Bullous pemphigoid responding to sulfapyridine and the sulfones
    • Person JR, Rogers RS 3rd,. Bullous pemphigoid responding to sulfapyridine and the sulfones. Arch Dermatol 1977; 113: 610-15.
    • (1977) Arch Dermatol , vol.113 , pp. 610-615
    • Person, J.R.1    Rogers III, R.S.2
  • 68
    • 0024556996 scopus 로고
    • Adjuvant therapy of bullous pemphigoid with dapsone
    • Jeffes EW, Ahmed AR,. Adjuvant therapy of bullous pemphigoid with dapsone. Clin Exp Dermatol 1989; 14: 132-6.
    • (1989) Clin Exp Dermatol , vol.14 , pp. 132-136
    • Jeffes, E.W.1    Ahmed, A.R.2
  • 69
    • 26244449650 scopus 로고    scopus 로고
    • Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: A retrospective study of 62 cases
    • Schmidt E, Kraensel R, Goebeler M, et al. Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases. Cutis 2005; 76: 205-9.
    • (2005) Cutis , vol.76 , pp. 205-209
    • Schmidt, E.1    Kraensel, R.2    Goebeler, M.3
  • 70
    • 28244474919 scopus 로고    scopus 로고
    • Childhood bullous pemphigoid successfully treated with diaminodiphenyl sulfone
    • Motegi S, Abe M, Tamura A, et al. Childhood bullous pemphigoid successfully treated with diaminodiphenyl sulfone. J Dermatol 2005; 32: 809-12.
    • (2005) J Dermatol , vol.32 , pp. 809-812
    • Motegi, S.1    Abe, M.2    Tamura, A.3
  • 71
    • 60449101298 scopus 로고    scopus 로고
    • A case of juvenile bullous pemphigoid - Successful treatment with diaminodiphenylsulfone and prednisone
    • Marcus KA, Halbertsma FJ, van Steensel MA,. A case of juvenile bullous pemphigoid-successful treatment with diaminodiphenylsulfone and prednisone. Pediatr Dermatol 2009; 26: 55-8.
    • (2009) Pediatr Dermatol , vol.26 , pp. 55-58
    • Marcus, K.A.1    Halbertsma, F.J.2    Van Steensel, M.A.3
  • 72
    • 0022383915 scopus 로고
    • Bullous pemphigoid and intravenous gammaglobulin
    • Godard W, Roujeau JC, Guillot B, et al. Bullous pemphigoid and intravenous gammaglobulin. Ann Intern Med 1985; 103: 964-5.
    • (1985) Ann Intern Med , vol.103 , pp. 964-965
    • Godard, W.1    Roujeau, J.C.2    Guillot, B.3
  • 73
    • 0024506906 scopus 로고
    • High-dosage intravenous gamma globulin: Therapeutic failure in pemphigus and pemphigoid
    • Tappeiner G, Steiner A,. High-dosage intravenous gamma globulin: therapeutic failure in pemphigus and pemphigoid. J Am Acad Dermatol 1989; 20: 684-5.
    • (1989) J Am Acad Dermatol , vol.20 , pp. 684-685
    • Tappeiner, G.1    Steiner, A.2
  • 74
    • 0029099584 scopus 로고
    • Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: Experience in six patients
    • Beckers RC, Brand A, Vermeer BJ, et al. Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients. Br J Dermatol 1995; 133: 289-93.
    • (1995) Br J Dermatol , vol.133 , pp. 289-293
    • Beckers, R.C.1    Brand, A.2    Vermeer, B.J.3
  • 75
    • 0032966225 scopus 로고    scopus 로고
    • High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: An evaluation of its use in 14 cases
    • Harman KE, Black MM,. High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. Br J Dermatol 1999; 140: 865-74.
    • (1999) Br J Dermatol , vol.140 , pp. 865-874
    • Harman, K.E.1    Black, M.M.2
  • 76
    • 0035185417 scopus 로고    scopus 로고
    • Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment
    • Ahmed AR,. Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 2001; 45: 825-35.
    • (2001) J Am Acad Dermatol , vol.45 , pp. 825-835
    • Ahmed, A.R.1
  • 77
    • 84863224822 scopus 로고    scopus 로고
    • High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid
    • Gaitanis G, Alexis I, Pelidou SH, et al. High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid. Eur J Dermatol 2012; 22: 363-9.
    • (2012) Eur J Dermatol , vol.22 , pp. 363-369
    • Gaitanis, G.1    Alexis, I.2    Pelidou, S.H.3
  • 78
    • 25844453682 scopus 로고    scopus 로고
    • Joint Formulary Committee. London: British Medical Association and Royal Pharmaceutical Society
    • Joint Formulary Committee. British National Formulary, vol. 63. London: British Medical Association and Royal Pharmaceutical Society, 2012.
    • (2012) British National Formulary, Vol. 63
  • 79
    • 49249115273 scopus 로고    scopus 로고
    • Department of Health. 2nd edn. updated 2011 last accessed 25 September 2012
    • Department of Health. Clinical Guidelines for Immunoglobulin use, 2nd edn. updated 2011. Available at: http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-085235 (last accessed 25 September 2012).
    • Clinical Guidelines for Immunoglobulin Use
  • 80
    • 0025284092 scopus 로고
    • The use of chlorambucil in the treatment of bullous pemphigoid
    • Milligan A, Hutchinson PE,. The use of chlorambucil in the treatment of bullous pemphigoid. J Am Acad Dermatol 1990; 22: 796-801.
    • (1990) J Am Acad Dermatol , vol.22 , pp. 796-801
    • Milligan, A.1    Hutchinson, P.E.2
  • 81
    • 9644255758 scopus 로고    scopus 로고
    • Chlorambucil as a steroid-sparing agent in bullous pemphigoid
    • Chave TA, Mortimer NJ, Shah DS, et al. Chlorambucil as a steroid-sparing agent in bullous pemphigoid. Br J Dermatol 2004; 151: 1107-8.
    • (2004) Br J Dermatol , vol.151 , pp. 1107-1108
    • Chave, T.A.1    Mortimer, N.J.2    Shah, D.S.3
  • 82
    • 0030010273 scopus 로고    scopus 로고
    • Successful treatment of bullous pemphigoid with pulsed intravenous cyclophosphamide
    • Itoh T, Hosokawa H, Shirai Y, et al. Successful treatment of bullous pemphigoid with pulsed intravenous cyclophosphamide. Br J Dermatol 1996; 134: 931-3.
    • (1996) Br J Dermatol , vol.134 , pp. 931-933
    • Itoh, T.1    Hosokawa, H.2    Shirai, Y.3
  • 83
    • 0030716948 scopus 로고    scopus 로고
    • Severe bullous pemphigoid responsive to pulsed intravenous dexamethasone and oral cyclophosphamide
    • Dawe RS, Naidoo DK, Ferguson J,. Severe bullous pemphigoid responsive to pulsed intravenous dexamethasone and oral cyclophosphamide. Br J Dermatol 1997; 137: 826-7.
    • (1997) Br J Dermatol , vol.137 , pp. 826-827
    • Dawe, R.S.1    Naidoo, D.K.2    Ferguson, J.3
  • 84
    • 4544338518 scopus 로고    scopus 로고
    • A case of refractory bullous pemphigoid with plasmapheresis-associated thrombopenia: Efficacy of pulsed intravenous cyclophosphamide therapy
    • Ogawa Y, Adachi A, Okamoto M, et al. A case of refractory bullous pemphigoid with plasmapheresis-associated thrombopenia: efficacy of pulsed intravenous cyclophosphamide therapy. J Dermatol 2004; 31: 651-4.
    • (2004) J Dermatol , vol.31 , pp. 651-654
    • Ogawa, Y.1    Adachi, A.2    Okamoto, M.3
  • 85
    • 0022835127 scopus 로고
    • Immediate treatment of bullous pemphigus with a corticosteroid- cyclophosphamide combination
    • Taieb A, Klene C, Maleville J,. Immediate treatment of bullous pemphigus with a corticosteroid-cyclophosphamide combination. Ann Dermatol Venereol 1986; 113: 1223-9.
    • (1986) Ann Dermatol Venereol , vol.113 , pp. 1223-1229
    • Taieb, A.1    Klene, C.2    Maleville, J.3
  • 86
    • 0022654251 scopus 로고
    • Cyclosporin in the treatment of bullous pemphigoid: Preliminary study
    • Barthelemy H, Thivolet J, Cambazard F, et al. Cyclosporin in the treatment of bullous pemphigoid: preliminary study. Ann Dermatol Venereol 1986; 113: 309-13.
    • (1986) Ann Dermatol Venereol , vol.113 , pp. 309-313
    • Barthelemy, H.1    Thivolet, J.2    Cambazard, F.3
  • 87
    • 0038797070 scopus 로고    scopus 로고
    • Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid
    • Chu J, Bradley M, Marinkovich MP,. Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. Arch Dermatol 2003; 139: 813-15.
    • (2003) Arch Dermatol , vol.139 , pp. 813-815
    • Chu, J.1    Bradley, M.2    Marinkovich, M.P.3
  • 88
    • 1842454216 scopus 로고    scopus 로고
    • The application of topical tacrolimus in vesicular pemphigoid
    • Chuh AA,. The application of topical tacrolimus in vesicular pemphigoid. Br J Dermatol 2004; 150: 622-3.
    • (2004) Br J Dermatol , vol.150 , pp. 622-623
    • Chuh, A.A.1
  • 89
    • 58449106550 scopus 로고    scopus 로고
    • Topical tacrolimus treatment for localized pretibial bullous pemphigoid
    • Calcaterra R, Carducci M, Franco G, et al. Topical tacrolimus treatment for localized pretibial bullous pemphigoid. J Eur Acad Dermatol Venereol 2009; 23: 177-9.
    • (2009) J Eur Acad Dermatol Venereol , vol.23 , pp. 177-179
    • Calcaterra, R.1    Carducci, M.2    Franco, G.3
  • 90
    • 0348012913 scopus 로고    scopus 로고
    • Topical tacrolimus therapy for localized bullous pemphigoid
    • Ko MJ, Chu CY,. Topical tacrolimus therapy for localized bullous pemphigoid. Br J Dermatol 2003; 149: 1079-81.
    • (2003) Br J Dermatol , vol.149 , pp. 1079-1081
    • Ko, M.J.1    Chu, C.Y.2
  • 91
    • 2342574805 scopus 로고    scopus 로고
    • Localized childhood vulval pemphigoid treated with tacrolimus ointment
    • Lebeau S, Mainetti C, Masouye I, et al. Localized childhood vulval pemphigoid treated with tacrolimus ointment. Dermatology 2004; 208: 273-5.
    • (2004) Dermatology , vol.208 , pp. 273-275
    • Lebeau, S.1    Mainetti, C.2    Masouye, I.3
  • 92
    • 33846204327 scopus 로고    scopus 로고
    • Rituximab in autoimmune bullous diseases: Mixed responses and adverse effects
    • Schmidt E, Seitz CS, Benoit S, et al. Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol 2007; 156: 352-6.
    • (2007) Br J Dermatol , vol.156 , pp. 352-356
    • Schmidt, E.1    Seitz, C.S.2    Benoit, S.3
  • 93
    • 49349089794 scopus 로고    scopus 로고
    • Severe bullous pemphigoid in an infant - Successful treatment with rituximab
    • Schulze J, Bader P, Henke U, et al. Severe bullous pemphigoid in an infant-successful treatment with rituximab. Pediatr Dermatol 2008; 25: 462-5.
    • (2008) Pediatr Dermatol , vol.25 , pp. 462-465
    • Schulze, J.1    Bader, P.2    Henke, U.3
  • 94
    • 41549133018 scopus 로고    scopus 로고
    • A new approach on bullous pemphigoid therapy
    • Saouli Z, Papadopoulos A, Kaiafa G, et al. A new approach on bullous pemphigoid therapy. Ann Oncol 2008; 19: 825-6.
    • (2008) Ann Oncol , vol.19 , pp. 825-826
    • Saouli, Z.1    Papadopoulos, A.2    Kaiafa, G.3
  • 95
    • 0036739404 scopus 로고    scopus 로고
    • Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease
    • Szabolcs P, Reese M, Yancey KB, et al. Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease. Bone Marrow Transplant 2002; 30: 327-9.
    • (2002) Bone Marrow Transplant , vol.30 , pp. 327-329
    • Szabolcs, P.1    Reese, M.2    Yancey, K.B.3
  • 96
    • 67349230604 scopus 로고    scopus 로고
    • Efficacy of rituximab in a case of refractory bullous pemphigoid
    • Reguiai Z, Tchen T, Perceau G, et al. Efficacy of rituximab in a case of refractory bullous pemphigoid. Ann Dermatol Venereol 2009; 136: 431-4.
    • (2009) Ann Dermatol Venereol , vol.136 , pp. 431-434
    • Reguiai, Z.1    Tchen, T.2    Perceau, G.3
  • 97
    • 80053045297 scopus 로고    scopus 로고
    • Bullous and mucous membrane pemphigoid show a mixed response to rituximab: Experience in seven patients
    • Lourari S, Herve C, Doffoel-Hantz V, et al. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients. J Eur Acad Dermatol Venereol 2011; 25: 1238-40.
    • (2011) J Eur Acad Dermatol Venereol , vol.25 , pp. 1238-1240
    • Lourari, S.1    Herve, C.2    Doffoel-Hantz, V.3
  • 98
    • 80051783440 scopus 로고    scopus 로고
    • Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients
    • Kasperkiewicz M, Shimanovich I, Ludwig RJ, et al. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients. J Am Acad Dermatol 2011; 65: 552-8.
    • (2011) J Am Acad Dermatol , vol.65 , pp. 552-558
    • Kasperkiewicz, M.1    Shimanovich, I.2    Ludwig, R.J.3
  • 99
    • 32644449004 scopus 로고    scopus 로고
    • Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept
    • Yamauchi PS, Lowe NJ, Gindi V,. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol 2006; 54: S121-2.
    • (2006) J Am Acad Dermatol , vol.54
    • Yamauchi, P.S.1    Lowe, N.J.2    Gindi, V.3
  • 100
    • 78049473647 scopus 로고    scopus 로고
    • Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: Two case reports
    • Boussemart L, Jacobelli S, Batteux F, et al. Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports. Dermatology 2010; 221: 201-5.
    • (2010) Dermatology , vol.221 , pp. 201-205
    • Boussemart, L.1    Jacobelli, S.2    Batteux, F.3
  • 101
    • 70349497499 scopus 로고    scopus 로고
    • Development of bullous pemphigoid during treatment of psoriasis with adalimumab
    • Stausbol-Gron B, Deleuran M, Sommer Hansen E, et al. Development of bullous pemphigoid during treatment of psoriasis with adalimumab. Clin Exp Dermatol 2009; 34: e285-6.
    • (2009) Clin Exp Dermatol , vol.34
    • Stausbol-Gron, B.1    Deleuran, M.2    Sommer Hansen, E.3
  • 102
    • 61549086236 scopus 로고    scopus 로고
    • Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab
    • Fairley JA, Baum CL, Brandt DS, et al. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab. J Allergy Clin Immunol 2009; 123: 704-5.
    • (2009) J Allergy Clin Immunol , vol.123 , pp. 704-705
    • Fairley, J.A.1    Baum, C.L.2    Brandt, D.S.3
  • 103
    • 84860343475 scopus 로고    scopus 로고
    • Successful management of severe infant bullous pemphigoid with omalizumab
    • Dufour C, Souillet AL, Chaneliere C, et al. Successful management of severe infant bullous pemphigoid with omalizumab. Br J Dermatol 2012; 166: 1140-2.
    • (2012) Br J Dermatol , vol.166 , pp. 1140-1142
    • Dufour, C.1    Souillet, A.L.2    Chaneliere, C.3
  • 104
    • 13844289191 scopus 로고    scopus 로고
    • Daclizumab: A novel therapeutic option in severe bullous pemphigoid
    • Mockenhaupt M, Grosber M, Norganer J,. Daclizumab: a novel therapeutic option in severe bullous pemphigoid. Acta Derm Venereol 2005; 85: 65-6.
    • (2005) Acta Derm Venereol , vol.85 , pp. 65-66
    • Mockenhaupt, M.1    Grosber, M.2    Norganer, J.3
  • 105
    • 33947182448 scopus 로고    scopus 로고
    • Drug-resistant bullous pemphigoid and inflammatory bowel disease in a pediatric case successfully treated by plasma exchange and extracorporeal photochemotherapy
    • Tripodi G, Risso M, Tenerini L, et al. Drug-resistant bullous pemphigoid and inflammatory bowel disease in a pediatric case successfully treated by plasma exchange and extracorporeal photochemotherapy. J Clin Apher 2007; 22: 26-30.
    • (2007) J Clin Apher , vol.22 , pp. 26-30
    • Tripodi, G.1    Risso, M.2    Tenerini, L.3
  • 106
    • 0037362495 scopus 로고    scopus 로고
    • Successful treatment by double-filtration plasmapheresis of a patient with bullous pemphigoid: Effects in vivo on transcripts of several genes for chemokines and cytokines in peripheral blood mononuclear cells
    • Hatano Y, Katagiri K, Arakawa S, et al. Successful treatment by double-filtration plasmapheresis of a patient with bullous pemphigoid: effects in vivo on transcripts of several genes for chemokines and cytokines in peripheral blood mononuclear cells. Br J Dermatol 2003; 148: 573-9.
    • (2003) Br J Dermatol , vol.148 , pp. 573-579
    • Hatano, Y.1    Katagiri, K.2    Arakawa, S.3
  • 107
    • 0037294082 scopus 로고    scopus 로고
    • Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid
    • Mazzi G, Raineri A, Zanolli FA, et al. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid. Transfus Apher Sci 2003; 28: 13-18.
    • (2003) Transfus Apher Sci , vol.28 , pp. 13-18
    • Mazzi, G.1    Raineri, A.2    Zanolli, F.A.3
  • 108
    • 23044438369 scopus 로고    scopus 로고
    • Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption
    • Herrero-Gonzalez JE, Sitaru C, Klinker E, et al. Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption. Clin Exp Dermatol 2005; 30: 519-22.
    • (2005) Clin Exp Dermatol , vol.30 , pp. 519-522
    • Herrero-Gonzalez, J.E.1    Sitaru, C.2    Klinker, E.3
  • 109
    • 0031261159 scopus 로고    scopus 로고
    • Immunoadsorption for the treatment of bullous pemphigoid
    • Ino N, Kamata N, Matsuura C, et al. Immunoadsorption for the treatment of bullous pemphigoid. Ther Apher 1997; 1: 372-6.
    • (1997) Ther Apher , vol.1 , pp. 372-376
    • Ino, N.1    Kamata, N.2    Matsuura, C.3
  • 110
    • 84863777059 scopus 로고    scopus 로고
    • Adjuvant treatment of recalcitrant bullous pemphigoid with immunoadsorption
    • Muller PA, Brocker EB, Klinker E, et al. Adjuvant treatment of recalcitrant bullous pemphigoid with immunoadsorption. Dermatology 2012; 224: 224-7.
    • (2012) Dermatology , vol.224 , pp. 224-227
    • Muller, P.A.1    Brocker, E.B.2    Klinker, E.3
  • 111
    • 0038808878 scopus 로고    scopus 로고
    • Childhood bullous pemphigoid: A clinicopathologic study and review of the literature
    • Fisler RE, Saeb M, Liang MG, et al. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature. Am J Dermatopathol 2003; 25: 183-9.
    • (2003) Am J Dermatopathol , vol.25 , pp. 183-189
    • Fisler, R.E.1    Saeb, M.2    Liang, M.G.3
  • 112
    • 37349011839 scopus 로고    scopus 로고
    • Bullous pemphigoid in infancy: Clinical and epidemiologic characteristics
    • Waisbourd-Zinman O, Ben-Amitai D, Cohen AD, et al. Bullous pemphigoid in infancy: clinical and epidemiologic characteristics. J Am Acad Dermatol 2008; 58: 41-8.
    • (2008) J Am Acad Dermatol , vol.58 , pp. 41-48
    • Waisbourd-Zinman, O.1    Ben-Amitai, D.2    Cohen, A.D.3
  • 113
    • 0031837759 scopus 로고    scopus 로고
    • Bullous pemphigoid and epidermolysis bullosa acquisita: Presentation, prognosis, and immunopathology in 11 children
    • Edwards S, Wakelin SH, Wojnarowska F, et al. Bullous pemphigoid and epidermolysis bullosa acquisita: presentation, prognosis, and immunopathology in 11 children. Pediatr Dermatol 1998; 15: 184-90.
    • (1998) Pediatr Dermatol , vol.15 , pp. 184-190
    • Edwards, S.1    Wakelin, S.H.2    Wojnarowska, F.3
  • 114
    • 36048936627 scopus 로고    scopus 로고
    • Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy
    • Sugawara N, Nagai Y, Matsushima Y, et al. Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy. J Am Acad Dermatol 2007; 57: 1084-9.
    • (2007) J Am Acad Dermatol , vol.57 , pp. 1084-1089
    • Sugawara, N.1    Nagai, Y.2    Matsushima, Y.3
  • 115
    • 34548163533 scopus 로고    scopus 로고
    • Childhood bullous pemphigoid treated by i.v. immunoglobulin
    • Xiao T, Li B, Wang YK, et al. Childhood bullous pemphigoid treated by i.v. immunoglobulin. J Dermatol 2007; 34: 650-3.
    • (2007) J Dermatol , vol.34 , pp. 650-653
    • Xiao, T.1    Li, B.2    Wang, Y.K.3
  • 116
    • 77957325401 scopus 로고    scopus 로고
    • Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy
    • Fox JC, Kenkare S, Petronic Rosic V, et al. Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy. Pediatr Dermatol 2010; 27: 537-9.
    • (2010) Pediatr Dermatol , vol.27 , pp. 537-539
    • Fox, J.C.1    Kenkare, S.2    Petronic Rosic, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.